These findings are supported by the work of Chiang et al. (72), who demonstrated that cblb-deficient mice efficiently rejected subcutaneously inoculated EL4 and EG7 lymphoma cells lacking B7 co-stimulatory molecules. The gene discussed is CBLB; the disease is lymphoma.